Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with “gene editing” for the Noonan Syndrome. Publication in the renowned journal “Circulation“.

CRISPR/Cas9 – GENE EDITING: New therapeutic approach for congenital heart defects
5. August 2020
Category :
News
Related Posts
26. Februar 2021
Heart problems cause disturbed gene activity in the ...
18. Februar 2021
The Max Planck Society honors the physicist and ...
9. Februar 2021
First application in humans: The BioVAT-HF-DZHK20 study intends ...